SCHEMBL828006

SCHEMBL828006

O=S(=O)(C=Cc1ccc(Br)cc1)Nc1ccc(Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 1/20 0.51
KMT2A Q03164 2/20 0.51
PKM P14618 1/20 0.51
PTGES2 Q9H7Z7 11/20 0.51
LMNA P02545 2/20 0.49
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
ALDH1A1 P00352 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL828005 1.00 TGM2 (0.51) TGM2KMT2APKMPTGES2LMNA
SCHEMBL827839 0.92 KMT2A (0.58) KMT2APKMPTGES2LMNAHDAC1
SCHEMBL827840 0.92 KMT2A (0.58) KMT2APKMPTGES2LMNAHDAC1
SCHEMBL827377 0.84 KMT2A (0.72) KMT2APKMPTGES2LMNAHDAC1
SCHEMBL827378 0.84 KMT2A (0.72) KMT2APKMPTGES2LMNAHDAC1
SCHEMBL1122567 0.84 KMT2A (0.72) KMT2APKMPTGES2LMNAHDAC1
SCHEMBL827959 0.84 KMT2A (0.62) KMT2APKMPTGES2LMNAALDH1A1
SCHEMBL1123001 0.84 KMT2A (0.71) KMT2APKMPTGES2LMNAALDH1A1
SCHEMBL827960 0.84 KMT2A (0.62) KMT2APKMPTGES2LMNAALDH1A1
SCHEMBL827806 0.81 ALDH1A1 (0.74) KMT2APKMPTGES2LMNAHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896401-B1 UNSATURATED SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES SYNTHESIS UNIV TEMPLE (US) 2013-04-10 EP claimed
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-05-14 US claimed
EP-1896401-B1 UNSATURATED SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES SYNTHESIS UNIV TEMPLE (US) 2013-04-10 EP disclosed
US-8143453-B2 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis Temple University—Of the Commonwealth System of Higher Education (US) 2012-03-27 US disclosed
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-05-14 US disclosed
EP-1896401-A2 UNSATURATED SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES SYNTHESIS Temple University of the Commonwealth System of Higher Education (US) 2008-03-12 EP disclosed
WO-2006091870-A2 UNSATURATED SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES SYNTHESIS TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis SULT2A1, SULT1A1, ARSA TGM2 1750/4885KMT2A 2578/4885PKM 3996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.